Biosenta (ZRO.CN) Stock Price

Biosenta Price

CLOSED
0.08
​
Market closed

Revenue at Biosenta has contracted by 39.3% per year over the past 11 years to 1,400.00 CAD. For Biosenta, the net margin of -159,121.4% is down versus -49,797.9% a few years ago.

Biosenta stock price

Access this data via the Eulerpool API

Biosenta business model & stock analysis

BIOSENTA, Inc. develops and manufactures a range of chemical compounds for household and industrial applications using encapsulated nanotechnology. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-09-22. The company also develops chemical compounds designed to eliminate harmful microorganisms, such as bacteria, fungi, and viruses for household and industrial uses, while ensuring safety for both humans and the environment. The company offers true Disinfectant and Tri-Filler. The true disinfectant is recognized by Health Canada for use in the fight against COVID-19. Its true technology leads the charge against the threat of superbug pathogens. The Tri-Filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-Filler are embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain to protect the drywall of buildings, objects, such as resin furniture, resin, textiles and others.

Frequently asked questions about Biosenta

Converted at the current exchange rate, the Biosenta share trades at 0.05 EUR (0.08 CAD).

The revenue cannot currently be calculated for Biosenta.

The profit cannot currently be calculated for Biosenta.

The P/E ratio cannot be calculated for Biosenta at the moment.

The P/S cannot be calculated for Biosenta currently.

The Eulerpool Quality Score for Biosenta is 2/10.

The ISIN of Biosenta is CA09072N2023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Biosenta is ZRO.CN. The ticker symbol is used to trade Biosenta shares on the stock exchange.

Fair ValueTerminal
0.07 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website biosenta.com
Country
Currency
CAD
Initial public offering
Sep 22, 2005
ISIN
CA09072N2023
Cusip
09072N202
Market capitalization
2.81 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
11.49
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
95.87 %
Last updated Oct 10, 2026, 3:50 PM

Biosenta Peer Group

Biosenta FIGI

ZRO:CN · BBG000PVFYG5ZRO:CF · BBG000PVG0K3ZRO:TG · BBG000PVG452ZRO:TW · BBG002JRC243ZRO:DG · BBG005XRHRD0ZRO:QF · BBG0086KF6Q3ZRO:QH · BBG0086KF6R2ZRO:TO · BBG00G8YGRY7ZRO:DL · BBG00K7X1N85ZRO:DM · BBG00K7XGWX1ZRO:DN · BBG00K7XX4G3ZRO:QG · BBG00LN9J6X8

All fundamentals and in-depth analysis of Biosenta

Our stock analysis for Biosenta stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosenta. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.